Puig, L, Pérez-Hernández, M. The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone. Dermatologic Therapy. 2024; 2024DOI:10.1155/2024/2351576. PMID:. IF:3.400(Q1/2D).

Pesqué, D, de Frutos, FJO, Navarro-Triviño, F, Sanz-Sánchez, T, Zaragoza-Ninet, V, Córdoba-Guijarro, S, Miquel-Miquel, J, Silvestre-Salvador, JF, González-Pérez, R, Ruiz-González, I, Mercader-García, P, Serra-Baldrich, E, Carrascosa-Carrillo, JM, Tous-Romero, F, Rodríguez-Serna, M, Gatica-Ortega, ME, Paredes-Suárez, C, Pastor-Nieto, MA, Chicharro, P, Andreu, M, Sánchez-Gilo, A, Pereyra-Rodríguez, JJ, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Gallardo, F, Pujol, RM, García-Doval, I, Borrego, L, Descalzo, MA, Giménez-Arnau, AM. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC). CONTACT DERMATITIS. 2026; 94(6)DOI:10.1111/cod.70089. PMID:41714111. IF:4.600(Q1/1D).

Gilaberte, Y, Yélamos, O, Cañueto, J, Serra-Guillén, C, Conti, A, Pajuelo, F, Lecchi, A, Cappello, V, Kostov, B, Padullés, L, Romanelli, M. Patient-and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study). Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104632. PMID:41864466. IF:(Q/D).

Tulleuda, R, Arias-Santiago, S, Armesto, S, Carrascosa, JM, Feltes, R, Pérez-Suárez, B, de la Cueva, P, López-Ferrer, A. Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104633. PMID:41864465. IF:(Q/D).

Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V, Ruiz-Villaverde, R. Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(6)DOI:10.1111/ijd.70185. PMID:41310412. IF:3.200(Q1/3D).

Figueras-Nart, I, Castillo, RO, Baldrich, ES. Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based study. Frontiers in Medicine. 2026; 13DOI:10.3389/fmed.2026.1769149. PMID:42058418. IF:3.000(Q1/2D).